approval · primary record
TOCILIZUMAB-AAZG
FDA · BLA · 2026-05-21
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-21 |
| Brand | TYENNE |
| Sponsor | FRESENIUS KABI USA |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:20.200Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TOCILIZUMAB-AAZG:2026-05-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.